Study Reveals New Insights into Tau Proteins and Alzheimer's Disease
A recent study from Columbia University has brought new insights into the origins of tau proteins, which are thought to play a crucial role in the progression of Alzheimer's disease. This discovery challenges long-held assumptions about the development of the most common form of dementia, potentially revealing new points of intervention that could slow the onset or mitigate the effects of neurodegeneration. Alzheimer's disease is characterized by the accumulation of two proteins: amyloid and tau. Amyloid is a misfolded fragment of a larger protein that can clump together into plaques in the spaces between nerve cells, while tau takes on a configuration that creates sticky knots inside neurons, particularly in the dendrites. Traditionally, it has been assumed that abnormal tau proteins detach from their scaffolding in the axon and drift into the dendrites, where they become tangled. However, the study led by neurologist Kapil Ramachandran has introduced a new method for mapping the locations where messenger RNA is translated into chains of amino acids. This technique, called STARFISH, allows researchers to visualize where specific RNA templates are being read within a cell without modifying the proteins during their generation, thus providing a more accurate representation of the protein manufacturing process. By applying STARFISH to neurons taken from mice, the researchers discovered that while the mRNA strands encoding tau proteins were distributed throughout the cell, they were only being translated in the dendrites, not in the axons. Ramachandran noted, "The field has largely focused on tau moving to the wrong place. Instead, we found that a vulnerable pool of tau is being made in dendrites all along." This finding raises questions about what typically protects this pool of tau and what changes occur when that protection fails. The researchers suspect that the twisted forms of tau are produced right from the start, where they tangle together and resist transport to other areas of the neuron. Previous research by Ramachandran's team identified a structure known as a neuroproteasome among the translation machinery, which is believed to eliminate misfolded proteins. The reasons for the failure of this process in certain cases remain an open question, but future investigations could explore these pathways to uncover new strategies for predicting and treating dementia. Ramachandran expressed hope that understanding these mechanisms could lead to new ways to ensure that tau proteins fold correctly and avoid pathological changes. This research was published in the journal Nature Neuroscience.




